• SENSEX 72,480.29
    -48.78 (--0.07%)
  • BANKNIFTY 54,633.05
    373.10 (+0.69%)
  • Avalon Tech
    2,171.00 778.15(%)
  • Bharti Airtel
    1,753.30 1,745.00(%)
  • NSE
    1,761.00 1,761.00(%)
  • Molbio Diagnosti
    1,368.00 1,686.50(%)
  • Apollo Hospitals
    8,063.00 6,680.00(%)
  • Innova Captab
    1,080.00 608.25(%)
  • Hero Motors
    152.58 156.03(%)
  • Meesho
    230.55 254.65(%)
  • Azad Engineering
    3,126.00 3,126.00(%)
  • Shadowfax Technologies
    278.10 98.60(%)
  • Cupid
    312.10 312.10(%)
  • L&T Finance Ltd
    264.75 234.90(%)
  • Lenskart Solut.
    698.00 725.00(%)
  • Reliance Industries
    1,196.30 1,611.20(%)
  • SS Retail
    761.45 888.00(%)
  • Sun TV Network
    664.60 664.60(%)
  • Solar Industries
    19,820.00 22,630.05(%)
  • PB Fintech.
    1,040.00 1,040.00(%)
  • National High
    168.00 142.00(%)
  • HDFC Bank
    709.70 682.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gujarat Themis Biosyn Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Themis
  • BSE Code : 216.0
  • ISIN : INE942C01045
387.60 -19 (-4.65%)
  • As on 30 Sep 2026 (EOD)

  • Today’s Low

    386.50

  • Today’s High

    408.60

  • Open

    404.10

  • Perv Close

    406.50

  • 52W Low

    225.05

  • 52W High

    479.00

Key Indicators

  • P/E(TTM)

    103.68

  • Mar.Cap (₹Cr.)

    5,044.68

  • Div & Yield %

    0.14

  • Book Value(₹)

    79.74

  • Debt-Equity Ratio

    -4.65

  • AGM Date

    30-Sep-2026

  • EPS

    3.74

  • P/E Ratio

    103.68

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    5,044.68

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    13.02

  • BV (₹)

    79.70

  • Sales( ₹ in Cr.)

    165.82

  • NP (in Cr.)

    46.68

  • NP Var(%)

    -4.0

  • Div%

    67.0

  • CPS (₹)

    4.60

  • EPS (₹)

    3.60

  • Traded Value (₹ in Lakhs)

    5,046.63

  • 52 Week High

    479.00

  • 52 Week Low

    225.05

  • Price BSE

    388.0

  • Price NSE

    388.00

  • Market Capital( in Cr.)

    5,046.63

  • P/C Ratio

    84.70

  • P/E Ratio

    108.20

  • Price Vs.BV

    3.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 165.82 150.80 169.82 148.39 114.85 90.56
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 165.82 150.80 169.82 148.39 114.85 90.56
Other Income 2.43 2.44 4.38 6.59 4.05 3.27
Stock Adjustments 9.03 1.27 -11.01 3.24 5.13 0.38
Total Income 177.28 154.51 163.19 158.22 124.03 94.21
EXPENDITURE :            
Raw Materials 30.43 25.78 25.67 29.73 21.75 15.75
Power and Fuel Cost 31.89 26.63 26.53 26.41 21.73 16.57
Employee Cost 14.99 11.44 10.21 7.75 7.08 7.11
Other Manufacturing Expenses 7.75 9.20 6.79 6.80 7.91 8.79
Selling and Administration Expenses 8.37 5.81 8.59 6.66 2.31 1.86
Miscellaneous Expenses 5.01 4.36 2.29 0.64 1.15 0.53
Employee Benefit Expenses 14.99 11.44 10.21 7.75 7.08 7.11
Less: Preoperative Expenditure 0.00 -0.01 -0.01 0.00 0.00 0.00
Total Expenses 98.43 83.24 80.09 77.99 61.94 50.61
Operating Profit 78.85 71.27 83.10 80.22 62.10 43.59
Interest 3.84 0.36 0.23 0.18 0.83 0.98
Gross Profit 75.01 70.91 82.87 80.04 61.27 42.61
Depreciation 12.92 5.37 3.54 2.58 2.23 1.73
Profit Before Tax 62.09 65.54 79.33 77.46 59.04 40.88
Current Tax 10.79 16.49 19.80 19.24 15.34 10.58
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.62 0.28 0.38 0.26 0.07 0.13
Reported Net Profit 46.68 48.77 59.16 57.97 43.62 30.18
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.01
Adjusted Net Profit 46.68 48.77 59.16 57.97 43.62 30.17
Adjustment below Net Profit 0.01 -1.42 -0.03 0.06 -0.08 -0.03
P & L Balance brought forward 237.33 191.79 139.56 93.74 60.36 32.61
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 7.30 1.82 6.90 12.20 10.17 2.40
P & L Balance carried down 276.71 237.33 191.79 139.56 93.74 60.36
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 67.00 67.00 100.00 108.00 220.00 0.00
Dividend Per Share(Rs) 0.67 0.67 1.00 5.40 11.00 0.00
Earnings Per Share-Unit Curr 4.28 4.48 8.14 39.90 30.03 20.77
Earnings Per Share(Adj)-Unit Curr 4.28 4.48 5.43 5.32 4.00 2.77
Book Value 26.41 22.79 27.72 102.66 71.11 48.14
Book Value(Adj)-Unit Curr 26.41 22.79 18.48 13.69 9.48 6.42

Shareholding Pattern

  • Promoter Group

    59.33%

  • Public Share Holding

    40.67%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 73,491,287 56.47 73,491,287 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,726,796 2.86 3,726,791 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 77,218,083 59.33 77,218,078 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 750 0.00 750 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 250 0.00 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 6,418,819 4.93 6,418,819 20
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,824,859 2.17 2,824,859 1
Mutual Funds / UTI 12,568,773 9.66 12,554,773 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,553,624 1.96 2,543,374 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 24,367,075 18.72 24,342,575 35
2] Non Institution
Bodies Corporate 3,445,106 2.65 3,418,106 166
Clearing Members 0 0.00 0 0
Directors of their Relatives 169,770 0.13 169,770 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,341,242 1.03 1,205,992 748
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,410,176 1.08 1,410,176 495
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,707,348 3.62 4,707,348 11
Individuals holding nominal share capital up to Rs. 1 lakh 16,676,095 12.81 15,734,510 25,400
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 816,810 0.63 816,310 34
Sub Total 28,566,547 21.95 27,462,212 26,855
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 130,151,705 100.00 129,022,865 26,899

Company Background

Gujarat Themis Biosyn LtdPharmaceuticals - Indian - Bulk Drugs

  • Gujarat Themis Biosyn Ltd
  • BSE Code : 216.0
  • ISIN : INE942C01045

  • Incorporation Year

    1981

  • Registered Office

    69/C GIDC Industrial Estate
    Valsad Dist, VAPI,
    Gujarat-396195

  • Telephone

    91-260-2430027

  • FAX

    91-260-2400639

  • Chairman

    Dinesh S Patel

  • Managing Director

    Sachin D Patel

  • Company Secretary

  • Auditor

    GMJ & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Gujarat Themis Biosyn Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Guj. Themis Bio. 387.75 168.25 165.82 103.68 18.05
Abbott India 27,149.40 7,217.19 6,929.05 35.73 43.78
Astrazeneca Phar 6,188.75 2,304.07 2,275.58 91.21 27.86
Sanofi India 3,058.80 1,857.10 1,837.40 21.76 54.17
Glaxosmi. Pharma 2,767.60 3,932.76 3,790.20 44.21 58.17
Novartis India 1,923.85 393.10 354.33 48.58 15.94
Cipla 1,350.00 20,102.60 18,979.95 35.48 13.88
Bliss GVS Pharma 695.35 773.53 729.81 64.62 12.51
Fermenta Biotec. 549.65 474.15 450.25 25.66 18.77
Amrutanjan Healt 514.30 520.13 502.55 27.55 24.16
Ambalal Sarabhai 39.51 19.52 3.94 73.17 6.77